Business · 13/04/2021Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Pediatric Oncology Subcommittee for Public Comment on Regulatory Issues
Summary
The FDA is hosting a public meeting of the Pediatric Oncology Subcommittee to gather input on regulatory issues, with a public docket established for comments on the meeting and its agenda
Original source language: Federal Register — Food and Drug AdministrationOpen original release →